You are viewing: UK Cold Plasma Market analysis
Part of: Cold Plasma Market (Global)

The UK Cold Plasma Market was valued at $32.71 Million in 2024 and projected to reach to $50.64 Million by 2029, representing a compound annual growth rate of 9.1%. The UK cold plasma market is poised for sustained expansion through 2029, driven by increasing NHS adoption, growing clinical evidence, and rising demand for non-invasive treatment solutions.

UK Cold Plasma Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Cold Plasma Market Trends and Insights

  • The UK's advanced healthcare infrastructure and strong adoption of innovative medical technologies are driving this expansion, with cold plasma applications gaining traction in wound healing, sterilization, and dermatological treatments.
  • The UK market benefits from significant investment in research and development, coupled with regulatory support from the MHRA and NHS integration initiatives that facilitate technology adoption across healthcare facilities. During the 2024-2029 forecast period, the UK cold plasma market is expected to grow at a compound annual growth rate (CAGR) of 9.1%, outpacing several European counterparts.
  • This growth trajectory reflects increasing clinical evidence supporting cold plasma efficacy, rising healthcare expenditure, and growing demand for non-invasive treatment options across UK hospitals and private clinics.
  • The UK's position as a leader in medical device innovation and its collaborative healthcare ecosystem position it as a key market for cold plasma technology development and commercialization within Europe..

Key Market Statistics

  • CAGR (2024-2029) 9.1% CAGR
  • Market Size, 2024 ~USD 32.71 Million
  • Forecast, 2029 ~USD 50.64 Million
  • Country UK

UK Cold Plasma Market Overview

Market Valuation :

The UK cold plasma market is valued at $32.71 million in 2024, with strong growth trajectory positioning it as a key segment within European healthcare innovation.

Robust Growth Rate :

The UK market is expanding at a CAGR of 9.1% through 2029, outpacing many traditional medical technology sectors and reflecting increasing clinical adoption.

Healthcare Infrastructure Advantage :

The UK's advanced NHS infrastructure and private healthcare sector provide ideal conditions for rapid deployment and integration of cold plasma technologies across multiple clinical settings.

Clinical Application Expansion :

Cold plasma is gaining significant traction in UK hospitals and clinics for wound healing, surgical sterilization, and dermatological treatments, driving market diversification.

UK Cold Plasma Market Dynamics

  • Healthcare providers across the UK are investing in cold plasma technology to enhance patient outcomes in wound care and infection control, supported by regulatory approvals and clinical validation.
  • The convergence of advanced healthcare infrastructure, skilled medical professionals, and strong R&D capabilities positions the UK as a leading adopter within Europe.
  • Market growth will be further accelerated by partnerships between UK medical device manufacturers and healthcare institutions, alongside increasing awareness among clinicians and patients regarding cold plasma's therapeutic benefits..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK cold plasma market is valued at $32.71 million in 2024 and is projected to reach $50.64 million by 2029, representing a 9.1% CAGR.
    • The UK's advanced healthcare infrastructure and NHS support are accelerating cold plasma adoption across wound care, sterilization, and dermatology applications.
    • Strong regulatory backing from the MHRA and increasing clinical evidence are driving market confidence and technology integration in UK healthcare facilities.
    • The UK market is positioned as a European leader in cold plasma innovation, supported by robust R&D investment and collaborative healthcare partnerships.

    Cold Plasma Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment MEDICAL INDUSTRY (Industry)
    Forecast Period 2024-2029
    Growth Rate CAGR of 11% from 2024 to 2029
    Largest Segment ATMOSPHERIC COLD PLASMA (Regime)
    Market Size Base Year (Billions) ~USD 2.14 (2024)
    Revenue Forecast (Billions) ~USD 3.6 (2029)
    Segments Covered Industry, Application, Regime

    UK Cold Plasma Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Industry

    • Cosmetic Industry
    • Electronics & Semiconductors Industry
    • Food & Agriculture Industry
    • Medical Industry
    • Other Industries
    • Polymer & Plastic Industry
    • Textile Industry

    By Application

    • Aesthetic Procedures
    • Coating & Thin-Film Deposition
    • Other Applications
    • Printing
    • Surface Cleaning & Decontamination
    • Surface Etching
    • Surface Treatment & Activation
    • Surgical
    • Wound Healing

    By Regime

    • Atmospheric Cold Plasma
    • Low-Pressure Cold Plasma

    UK: COLD PLASMA MARKET, BY INDUSTRY, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    COSMETIC INDUSTRY2.382.452.572.752.933.163.433.750.08
    ELECTRONICS & SEMICONDUCTORS INDUSTRY17.0917.919.1620.8522.6424.8427.5130.60.1
    FOOD & AGRICULTURE INDUSTRY5.926.146.57.017.548.28.999.910.09
    MEDICAL INDUSTRY6.787.257.948.839.811112.4514.160.12
    OTHER INDUSTRIES0.960.971.011.071.121.191.281.380.07
    POLYMER & PLASTIC INDUSTRY29.5630.7632.7135.3838.1841.6345.8150.640.09
    TEXTILE INDUSTRY20.4421.1222.3123.9625.6727.7930.3733.340.08
    TOTAL83.1386.5992.2199.85107.9117.81129.84143.780.09

    Target Audience

    • Medical Device Manufacturers : UK and international device makers need market-specific data to develop localized product strategies, understand NHS procurement requirements, and identify partnership opportunities with British healthcare institutions.
    • Healthcare Investors & PE Firms : Investment professionals require detailed UK market analysis to evaluate portfolio opportunities, assess growth potential, and make informed funding decisions in the cold plasma healthcare sector.
    • NHS Hospital Networks & Trusts : UK healthcare administrators need evidence-based market insights to justify technology adoption, benchmark against peer institutions, and optimize procurement decisions for cold plasma systems.
    • Clinical Research Institutions : UK universities and research centers require market data to identify funding opportunities, understand clinical adoption trends, and align research initiatives with commercial market demands.
    • Healthcare Consultants & Advisors : Strategy consultants serving UK healthcare clients need comprehensive market intelligence to provide evidence-based recommendations on technology adoption, competitive positioning, and market expansion strategies.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise UK market valuations ($32.71M in 2024) and verified forecasts through 2029, enabling accurate financial planning and investment decisions specific to the British market.
    • Competitive Landscape Intelligence : Understand UK-specific market dynamics, key players, and competitive positioning to identify partnership opportunities and market entry strategies tailored to British healthcare providers.
    • Clinical Application Insights : Gain detailed analysis of cold plasma adoption across UK wound healing, sterilization, and dermatology sectors, with insights into NHS procurement patterns and hospital adoption rates.
    • Regulatory & Reimbursement Framework : Obtain comprehensive understanding of UK regulatory pathways, NICE guidelines, and NHS reimbursement mechanisms critical for product commercialization and market penetration strategies.
    • Strategic Growth Opportunities : Identify high-potential segments, emerging applications, and geographic hotspots within the UK market to prioritize resource allocation and maximize ROI on healthcare technology investments.

    Frequently asked questions

    What is the current size of the UK cold plasma market in 2024?

    The UK cold plasma market is valued at $32.71 million in 2024, reflecting strong adoption of cold plasma technologies across UK healthcare institutions.

    What is the projected market size for the UK cold plasma market by 2029?

    The UK cold plasma market is forecast to reach $50.64 million by 2029, growing at a 9.1% CAGR during the 2024-2029 period.

    What are the primary applications of cold plasma in the UK healthcare market?

    In the UK, cold plasma is primarily used for wound healing, medical device sterilization, dermatological treatments, and infection control across hospitals and private clinics.

    What regulatory framework governs cold plasma devices in the UK?

    The UK Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and regulation of cold plasma medical devices, ensuring safety and efficacy standards.

    What factors are driving growth in the UK cold plasma market?

    Key growth drivers include increasing clinical evidence, NHS adoption initiatives, rising healthcare expenditure, demand for non-invasive treatments, and strong R&D investment in the UK.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Plasma Protein Therapeutic Association (PPTA), International Diabetes Federation (IDF),European Textile Services Association (ETSA), National Council of Textile Organizations (NCTO), Semiconductor Industry Association (SIA), International Journal of Plastic and Polymer Technology (IJPPT), International Journal of Engineering Research & Technology (IJERT and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global cold plasma market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the cold plasma market. The primary sources from the demand side include hospitals & clinics, physiotherapy clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global cold plasma market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global cold plasma market was split into various segments and sub-segments based on:

    • List of major players operating in the cold plasma   products market at the regional and/or country level
    • Product mapping of various cold plasma   manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from cold plasma (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Data Triangulation

    After arriving at the overall size of the global cold plasma market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and excited & ground-state molecules. It is an innovative and convenient alternative to traditional and conventional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.

    Stakeholders

    • Cold plasma manufacturers and distributors
    • Government and research organizations
    • Cold plasma application industries
    • Medical device manufacturing companies
    • Healthcare organizations
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Corporate entities

    Report Objectives

    • To define, measure, and describe the global cold plasma  market by industry, application, regime, and region
    • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
    • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, and patent analysis
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To strategically analyze the market structure, profile the key players in the global cold plasma  market, and comprehensively analyze their core competencies
    • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the cold plasma  market

    Get the Full Cold Plasma Market Report

    Full forecast, segment splits, and company analysis for all Cold Plasma Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status